Web Results


Dec 22, 2016 ... Watson Pharms., Inc., 11-cv-2340 (SDNY); Shire LLC v. Neos Therapeutics, Inc., 13-cv-1452 (N.D. Tx.); Shire LLC v. Colony, Pharms. Inc.


Mar 10, 2017 ... March 10 (Reuters) - Neos Therapeutics Inc. * On March 6, 2017, Neos Therapeutics entered into a license agreement with Shire - SEC filing.


Jan 29, 2016 ... Neos Therapeutics Inc. secured final FDA approval late Wednesday for ... and the bioequivalent of Shire PLC's Adderall XR, said the company, whose local ... to take medicine that dissolves on the tongue "vs. a pill or capsule.


Neos Therapeutics, Inc. is a pharmaceutical company focused on the development, manufacturing and commercialization of ADHD medications.


Jan 27, 2016 ... January 27, 2016 19:46 ET | Source: Neos Therapeutics, Inc. DALLAS and .... 1 Adderall XR® is registered to Shire plc. 2 National Institute of ...


Mar 8, 2017 ... Acorda Therapeutics, Inc. v. Mylan. Pharm., Inc., 817 ..... 15. Script Sec. Sols. L.L.C. v. Amazon.com,. Inc., 170 F. Supp. 3d 928 (E.D. Tex. 2016) . ... Shire LLC v . Abhai LLC, No. ... 15. Shire LLC v. Neos Theraputics, Inc., No.


LLC v. Yeda Research & Development Co. Ltd., PGR2016-00028 (PTAB), July 12, 2016, N/A .... Shire Development LLC v. ... Neos Therapeutics, Inc. v. Actavis  ...


Get the latest Neos Therapeutics, Inc. NEOS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which .... Pharma Stock Roundup: NVS Scores with Positive Data, Shire. .... Consort Medical PLC Sponsored ADR, CSRMY.


Websites. Company Website ... Neos Therapeutics Announces FDA Approval of Cotempla. ... Unbelievably excited to be joining Oxford Biomedica Plc. A.. ... Shire Pharmaceuticals ... r · s · t · u · v · w · x · y · z · more; Browse members by country.


Shire LLC v. Neos Therapeutics, Inc.*. Represented patentee in Hatch-Waxman litigation relating to ADDERALL XR patents. (N.D. Tex. 2014) ...